Showing results (491-500 of 1,193) with videos related to

Sort By:
Pageof 120
Investigational New Drugs|June 1, 1988
Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administrationA M Maddox, E J Freireich, M J Keating, et al.
Cancer|May 15, 1987
The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemiaR Dekmezian, H M Kantarjian, M J Keating, et al.
Southern Medical Journal|July 1, 1989
Necrotizing gas-forming infections in cancer patientsD Z Chu, V Fainstein, G P Bodey, et al.
Cancer Treatment Reports|October 1, 1978
Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusionP Salem, S W Hall, R S Benjamin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)K Lu, N Savaraj, J Kavanagh, et al.
Journal of Chemotherapy (Florence, Italy)|March 10, 2001
Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicansG Samonis, S Maraki, I Hajiioannou, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1994
In vitro activity of FK-037, a novel parenteral cephalosporin, against bacterial isolates from neutropenic cancer patientsN Dholakia, K V Rolston, D H Ho, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1989
Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution methodA Reuben, E Anaissie, P E Nelson, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
In vitro suppression of DNA synthesis by a remission induction agent and its correlation with response in adult acute leukemiaA M Maddox, D A Johnston, B Barlogie, et al.
Leukemia|January 1, 1995
Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromesJ E Cortes, H Kantarjian, S O'Brien, et al.
Pageof 120